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ABSTRACT 
 
   Purpose: To improve the reproducibility of patient positioning in fractionated irradiation and to achie-
ve uniform irradiation of the patient, within 12-15Gy, excluding the lungs. 
   Method: Two special body frames were manufactured, one for treatment planning and the other 
for the treatment itself. Special tin markers were inserted in the walls to make it possible for a patient 
to maintain the same position during each fraction of irradiation. Patient treatment was carried out 
in six fractions (four lateral and two AP/PA fields), twice a day, over three consecutive days. The lungs 
were shielded during AP/PA fractions and during one lateral fraction. The shape of the shields 
for AP/PA fields was determined with the use of computer tomography scans, and for lateral fields 
on the basis of radiographic pictures taken by a simulator. The doses calculated at some selected 
anatomical points for every patient were checked by in vivo measurements which were carried out 
by means of MOSFET detectors. 
   Results and conclusions: Reproducibility of patient positioning during consecutive treatments 
and a uniform total dose distribution over the range of 12 – 15 Gy (except in the lungs) have been 
achieved. This has been confirmed by in vivo measurements.  
 
   Key words: TBI, in vivo dosimetry, MOSFET detectors. 
 
INTRODUCTION 
 
   Total body irradiation (TBI) is a method 
of preparing patients with haematological 
malignancies for bone marrow trans-
plantation. This technique has been in use 
since the late 1970s [1]. Originally, TBI 
was applied in the form of a single irra-
diation. Following reports of late toxicity 
and late effects of this mode of irradiation, 
a fractionated TBI schedule has been 
adopted [2,3]. Buchali and co-workers [1] 
have analysed the immediate toxicity 
in patients undergoing fractionated TBI 
schedules. A number of irradiation tech-
niques and schedules are now in use [4,5]. 
The choice of treatment technique varies 
from centre to centre and depends on 
the treatment room geometry and the type 
of treatment unit and dose rate available 
[6]. 
   At the Leszczyński Memorial Hospital 
in Katowice, Poland, we have developed 
a technique of fractionated TBI. The main 
aim of our paper was to assure the same 
arrangement of every patient during indi-
vidual fractions of irradiation. Therefore, 
special body frames were designed for this 
purpose. These body frames are descry-
bed below. 
 
MATERIAL AND METHOD 
 
Patient Irradiation 
 
   Since August 2000 fifteen patients have 
been irradiated (their age ranging from 
18 to 48 years). All patients were treated 
in collaboration with the Department 
of Haematology and Bone Marrow 
Transplantation of the Silesian Medical 
Academy in Katowice. Patient data are 
presented in Table 1. 
   The procedure for preparing to irra-
diation  is  as  follows:  For  every  patient, 
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prior to computer tomography, a simu-
lation of patient’s arrangement in a special 
body frame had been carried out. In order 
to achieve high reproducibility of patient 
positioning in each fraction of irradiation, 
two special body frames were made, one 
for treatment planning (Fig. 1) and the ot-
her for the treatment itself (Fig. 2). 
In the walls of the body frame, made 
of 1 cm-thick plexiglass plates, special tin 
markers were inserted. Special marks 
were drawn on the patient’s skin during 
simulation at places where the laser light 
went through the selected markers on 
the body frame walls. These marks helped 
to arrange a patient in the same position 
during computer tomography and later 
during each fraction of irradiation. They 
also represented points at which in vivo 
measurements were made. Tin markers 
on body frames walls facilitated repro-
duction of the patient's position during 
irradiation, and were also helpful in deter-
mining the representative sites on the pa-
tient's body for which dose calculations 
were prepared using the Helax treatment 
planning system. Afterwards points which 
were drawn on the treatment planning 
body frame were copied onto the treat-
ment body frame walls. This was possible 
because the markers were placed 
identically on the walls of both body 
frames. 
 
Tab. 1. Data on patients treated by a total body irradiation 
technique. 
 
Diagnosis Number of patients 
 
Leucemia lymphoblastica acuta 
 
Lymphoma malignum  
 
Plasmocytoma 
 
Lymphogranulomatosis malignum. 
 
Ca embryonale et yolk sac tumor 
mediastini 
 
 
9 
 
3 
 
1 
 
1 
 
1 
 
Total 
 
15 
 
 
   The total prescribed dose delivered 
to the PC, a reference point defined at the 
intersection of the beam axis with the mid-
plane of the patient irradiated laterally, 
was 12 Gy in 10 cases, and 13,2 Gy 
in 5 cases, and was delivered in six 
fractions over three consecutive days. 
A total body dose should be uniformly 
distributed in the range of 12 – 15 Gy (total 
dose to the lungs not exceeding 9 Gy). 
15 MV photons from a Primus (Siemens) 
linear accelerator were employed. The pa-
tient was treated by a combination 
of the following fields: lateral fields 
at a SSD of 330 cm, and AP/PA fields 
at 135 cm. The dose-rate measured 
at a depth of 10 cm in a water phantom 
for lateral fields was 4,3 cGy/min., 
and for AP/PA fields was 23,6 cGy/min, 
at the respective SSD values.   
   The lungs during AP/PA fractions were 
protected by shields made of 7 cm Wood 
alloy, the shape of which was determined 
from CT (computer tomography) scans. 
For each patient, a set of CT scans was 
taken, with the patient in a supine position 
placed in the body frame. 
   For each patient, an irradiation schedule 
was prepared with an appropriate dose 
to the PC. An example of such a schedule 
is shown in Tables 2a and 2b. The AP/PA 
fractions, number 4 and number 6 in Table 
2a, were split into four (I – IV) individual 
54 cm x 54 cm irradiation fields, 
at SSD = 135 cm. The irradiation was 
carried out twice a day, with an eight-hour 
break, for three consecutive days. 
Individual fields I, II, III, and IV covered 
the head-and-neck, chest-to-pelvis, pelvis-
to-knees and the remaining parts of pa-
tient’s legs, respectively. 
   Shield positions were determined by 
the Helax planning system and were 
checked before each AP/PA fraction. 
Shields were then fastened to plexiglass 
trays inserted in the head of the Primus 
linear accelerator. The lungs were also 
shielded during one lateral fraction. 
The shape of this shield was established 
from radiographic pictures taken by 
a simulator. During treatment, patients 
were positioned supine in the treatment 
body frame, with their arms behind 
the head (Fig. 2). In order to improve 
the uniformity of dose distribution, the 
volume between the patient and the walls 
of the body frame was filled with bags with 
rice constituting a bolus (see Fig. 3).  
The density of rice, 1,37 g/cm3 was taken 
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into account in treatment planning.  
For irradiation with lateral fields, patients 
had their knees drawn upwards (see 
Fig. 3). The electron boost to the thorax 
wall (shielded for 15 MV photons) was 
delivered with 6 MeV or 9 MeV electron 
beams. 
 
 
 
Fig. 1. Body frame for treatment planning. 
 
 
 
 
 
Fig. 2. Patient’s arrangement in the therapeutic body frame. 
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Tab. 2a. Schedule of total body irradiation. 
 
 
Time 
of irradiation 
 
Number 
of fraction Field’s type 
SSD 
[cm] 
Delivered 
dose to PC 
[cGy] 
Anatomical points 
for in vivo 
measurements 
(see table 3) 
1st day 
morning 
 
1 
1 
Lateral Left 
Lateral Right 
330 
330 
100 
100 
1,2,3,4 
1,2,3,4 
1st day 
afternoon 
 
2 
2 
Lateral Left 
Lateral Right 
330 
330 
100 
100 
6,6a 
6,6a 
2nd day 
morning 
3 Lateral Left 
shielded for a half 
of time 
 
330 
 
100 
 
3,4 
 3 Lateral Right 
shielded for a half 
of time 
 
330 
 
100 
 
3,4 
2nd day 
afternoon 
4 AP 4 fields 
See Tab.1b 
135 100 2,7,2a,9,5,5a,6,6a 
 4 
 
 
PA 4 fields 
See Tab.1b 
135 100 6,6a 
3rd day  
morning 
5 
5 
Lateral Left 
Lateral Right 
330 
330 
100 
100 
7,8,10,5,5a 
  
      
3rd day 
afternoon 
6 
 
AP 4 fields 
See Tab.1b 
135 100 7,8,9,10,6 
 6 PA 4 fields 
See Tab.1b 
135 100 7a,8a,9a,10a, 
6a 
 7 AP electron beam 100 200*  
 7 PA electron beam 100 200*  
 
*  Dose delivered to thorax wall. 
 
Abbreviations: AP : Anterior – Posterior, PA : Posterior – Anterior, PC : reference point at the beam axis in the mid - plane from 
the lateral fields. 
 
 
Tab. 2b. Schedule of AP/PA fractions split into four 54 cm × 54 cm fields at SSD 135 cm. 
 
Time 
of irradiation 
Fraction 
number 
Field 
type 
Field 
number 
Anatomical points 
for in vivo 
measurements 
(see table 3) 
 
 
2nd day 
afternoon 
 
 
 
4 
 
 
AP and PA 
 
I 
II 
III 
IV 
 
2,7,7a (1 or 1a) 
8,9,10,3,4 
5 
6 
 
3rd day       
afternoon 
 
 
6 
 
 
AP and PA 
 
I 
II 
III 
IV 
 
2,7,7a ( 1 or 1a) 
8a,9a,10a,3a,4a 
5 
6 
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Fig. 3. Patient’s arrangement after filling the therapeutic body frame with rice bags. 
 
Dose calculation 
 
   For each patient, twenty anatomical 
points, listed in Table 3, were determined.  
At these points (on the patient’s skin) 
the doses were calculated and in vivo 
measurements carried out by means 
of MOSFET (Metal-Oxide Semiconductor 
Field Effect Transistor) detectors [7,8]. 
 
Tab. 3. List of anatomical points for in vivo measurements. 
 
Point’s 
number Place on the patient’s body 
1 Right side of the arm (1/2 AP) 
1a Left side of the arm (1/2 AP)  
2 Right side of the head (temple 1/2 AP) 
2a Left side of the head (temple 1/2 AP) 
3 Right side of the chest (1/2 AP)  
3a Left side of the chest (1/2 AP) 
4 Patient’s right side in the middle 
of beam (PC, 1/2 AP) 
4a Patient’s left side in the middle of beam 
(PC, 1/2 AP) 
5 Knee (right side) 
5a Knee (left side) 
6 Foot (ankle joint) right side 
6a Foot (ankle joint) left side 
7 Forehead 
7a Back of the head 
8 Top of the chest 
8a Back of the chest 
9 Top of the chest under the lung shield 
9a Back of the chest under the lung shield 
10 Point on the abdomen in the middle 
of patient’s length (PC) 
10a Point on the back in the middle 
of patient’s length (PC) 
 
 
   The MOSFET detectors were connected 
to a bias supply. After irradiation, the de-
tector was connected to a readout device. 
The MOSFET detector can accumulate 
a voltage shift of about 20 V. The sensitive 
volume of the detectors, of less than 
1 mm3, is encapsulated by approximately 
2 mm of epoxy resin, making the detector 
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flat on one side and hemi-spherical on the 
epoxy side. The MOSFET detectors were 
calibrated in a water phantom under 
conditions of electron equilibrium, using a 
Farmer 0,6 cm3 chamber. The calibra- 
tion coefficient was determined for all five 
detectors and was equal to 0,906 cGy/mV 
(standard deviation, SD = 0,0163 cGy/mV). 
The value of the calibration coefficient did 
not depend on the side of detector 
irradiated, within ± 0,1%. The signal 
of the MOSFET detectors was read out 
in mV.  
   As only five MOSFET detectors were 
available for dose measurements, their 
locations were changed from one point 
to another (see Table 2a and Table 2b) 
in each exposure. Additionally, at some 
selected anatomical points, ionisation 
chamber measurements with build-up cup 
were also performed.  
   For lateral field irradiation, doses were 
calculated using percentage depth dose 
values PDD (SSD =330 cm, field 40 cm 
x 40 cm at SSD 100 cm) and the radiation 
beam profile presented in Fig. 4. The PDD 
and the profile were experimentally deter-
mined in a water phantom. The profile was 
measured using a 0.6 cm3 ionization 
chamber placed in a water phantom 
at a depth of 6 cm. The 40 cm x 40 cm 
x 40 cm phantom was located 
at SSD = 330 cm and was moved across 
the radiation beam.  
   To calculate doses for the AP/PA fields, 
the algorithm of the Helax treatment 
planning system was used. The correction 
for lung density was taken into account 
for the lateral and AP/PA fields. 
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Fig. 4. Beam profile for 15 MV photons (Primus accelerator), measured in water at a depht of 6 cm at SSD = 330 cm. 
 
 
RESULTS AND DISCUSSION 
 
   Fig. 5 shows the largest discrepancy 
between the calculated and measured 
values of the total dose, against the dose 
prescribed to the PC, for all 15 patients. 
The data indicate that for all patients 
the values of the calculated total dose 
 
at all the twenty points listed in Table 3, 
apart from those prescribed to the PC, 
ranged between 12 Gy and 14,7 Gy (ex-
cluding the lungs). The values of the cal-
culated dose higher than those to the PC 
resulted from the shape of the radiation 
beam profile (Fig. 4). 
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   For no patient did the maximum value 
of the measured total dose exceed 
the value of 15 Gy. In seven patients, 
the minimum value of the measured total 
doses was found to be smaller than 12 Gy. 
For these patients the prescribed total 
dose to the PC was 12 Gy, and the mini-
mum measured total dose was obtained 
from detectors placed on the skin surface 
on the top of their chest (point number 8, 
Table 3). In this case, the conditions 
of electron equilibrium around the detector 
were not fulfilled, for lateral field 
irradiation, leading to underestimation 
of the measured dose value. To confirm 
this finding, during irradiation of patients 
14 and 15 the detector was covered 
by a rice bag, leading to a reduction 
in the discrepancy between the calculated 
and measured value of the dose on 
the skin of the top of the chest. It seems 
that for in vivo dosimetry in the TBI 
technique MOSFET detectors offer an ad-
vantage against semiconductor diodes.  
MOSFET detectors, being calibrated 
in water under electron equilibrium con-
ditions, are able to evaluate the dose on 
the skin, whereas a diode, covered 
by build-up material, provides the value 
of dose at a maximum dose depth. 
   Our treatment body frame enabled 
the patient’s position to be stable during 
irradiation, making the lung shields 
in AP/PA and lateral fields reliable. 
 
 
CONCLUSION 
 
   The results presented in Fig. 5 show that 
the dose distribution in the patient's body 
was consistent within the required limits 
of 12 Gy – 15 Gy. In conclusion, we can 
state that the required uniformity of dose 
distribution has been achieved. 
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Fig. 5. Values of the total dose prescribed to the PC reference point, and of maximum and minimum values calculated 
and measured for individual patients.  Horizontal lines represent the required range of uniformity of total dose values. 
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